©The Author(s) 2023.
World J Diabetes. May 15, 2023; 14(5): 512-527
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.512
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.512
Table 1 Pathophysiologic mechanisms connecting type 2 diabetes mellitus and Atrial Fibrillation
| Involved mechanism | Result | |
| Structural remodelling | Inflammation | Atrial fibrosis and dilatation |
| Oxidative stress | ||
| Expression of profibrotic growth factors | ||
| Enhanced collagen synthesis and high fibroblast activity | ||
| Activation of the (RAAS) system | ||
| Obesity and adiposity | ||
| Electrical remodelling | Longer activation times | Conduction abnormalities |
| Abnormal current densities and refractory periods | ||
| Electromechanical delay | ||
| Affected gap junction function | ||
| Autonomic dysfunction | Downsizing of parasympathetic nervous system | Autonomic imbalance |
| Upregulation of sympathetic stimuli | ||
| Glycemic parameters | Sympathetic activation due to hypoglycaemia | AF susceptibility |
| Remodelling due to chronic hyperglycemia | ||
| Oxidative stress and fibrosis due to glycemic fluctuations | ||
| Fibrosis due to adipokines |
- Citation: Leopoulou M, Theofilis P, Kordalis A, Papageorgiou N, Sagris M, Oikonomou E, Tousoulis D. Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment. World J Diabetes 2023; 14(5): 512-527
- URL: https://www.wjgnet.com/1948-9358/full/v14/i5/512.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i5.512